Clofezone
| Combination of | |
|---|---|
| Clofexamide | Antidepressant |
| Phenylbutazone | Non-steroidal anti-inflammatory drug |
| Clinical data | |
| Trade names | Perclusone |
| Routes of administration | Oral, rectal, topical |
| ATC code | M02AA03 (WHO) M01AA05 (WHO) |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
17449-96-6 |
| PubChem (CID) | 6433695 |
| ChemSpider |
4938775 |
| UNII |
5RB28NE79Y |
| | |
Clofezone (trade name Perclusone) is a drug that was used to treat joint and muscular pain, but is not marketed any more. It is a combination of clofexamide, an antidepressant, and phenylbutazone, a non-steroidal anti-inflammatory drug (NSAID).[1][2]
References
- ↑ Berger, Artur; Wachter, Helmut, eds. (1998). Hunnius Pharmazeutisches Wörterbuch (in German) (8 ed.). Walter de Gruyter Verlag. p. 343. ISBN 3-11-015793-4.
- ↑ Reinicke, C.; Helbing, M.; Klingenfeld, U.; Lasaroff, I.; Wessel, G. (1984). "Comparative studies on the bioavailability of various drug forms of phenylbutazone and clofezone (Perclusone)". Die Pharmazie. 39 (12): 824–827. PMID 6241720.
This article is issued from Wikipedia - version of the 11/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.